Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: RXMD

Progressive Care Begins Development of Proprietary Tele-pharmacy Software for Exclusive Use

Leading Florida-Based Healthcare Services and Technology Company Expands its Kiosk Program in Florida

MIAMI, May 24, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced that the company has started the development of its own proprietary tele-pharmacy software in order to digitally communicate with patients, physicians, pharmacists and caretakers across the world.

The move comes as part of Progressive Care’s overall effort to expand its current kiosk program throughout the state of Florida. The company has hired six new software coders to work alongside Mass Ventures Corporation and deliver a state of the art multi-platform technology capable of running on kiosk, desktop, and mobile devices. In addition to developing its own proprietary software, the new team will also be updating the website of the company wholly owned subsidiary, PharmCo, LLC.

“Our success with prescription management has allowed us to begin developing our own proprietary tele-pharmacy software. After configuring a third-party platform in our kiosks, we realized the need to develop a more customized solution for our customers,” said S. Parikh Mars, CEO of Progressive Care Inc. “We believe that with the completion of this new software, along with Progressive Care’s current contingent of pharma-robotic equipment, we will be that much closer to becoming the leader in personalized healthcare services and technology.”

Mars continued, “Progressive Care remains committed to evolving the technology of our tele-pharmacy services. This is one of many steps we are taking to expand the technological development of the Company.”

The new software will be designed with a secure interface for both providers and patients to offer a more personalized healthcare experience for both audiences. Additionally, a new design and database modeling will be integrated into the program.

Progressive Care continues to add to its healthcare technology offering through the purchase of a new TCGRx Automated Pouch Packing System for its Miami-Dade County PharmCo location, set to be installed in June 2018. The company also recently announced the rollout of its online prescription management solution, as well as its decision to begin accepting Bitcoin payments from customers in February of 2018.

For more information about Progressive Care, please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care Inc.
Progressive Care Inc. (OTCQB:RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact:
Tory Patterson, CMW Media
Public Relations Consultant
Tory@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:
Armen Karapetyan
Progressive Care Inc
Senior Business Development Consultant
Pharmco, LLC
General Manager
Phone: 305-919-7399 ext. 201
Fax: 305-945-8098
armen@progressivecareus.com

Posted in Client News| Tagged |

Progressive Care Purchases TCGRx Pouch Packaging System to Add to Expanding Robot Pharmacy Machinery Fleet

MIAMI, May 22, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced that the company has purchased a new TCGRx Automated Pouch Packaging System for its Miami-Dade County PharmCo location, which is to be installed in the beginning of June 2018.

Progressive Care’s wholly owned subsidiary, PharmCo, LLC located in Miami Beach, will be one of the first in South Florida to offer patients the benefit of this new packaging system that allows for patients to receive customized dosage pouches according to their daily prescription needs.

“We understand that patients continue to struggle with taking their medications on time and as prescribed and one of our core missions is to eliminate the obstacles patients experience that lead to non-adherence,” said S. Parikh Mars, CEO of Progressive Care Inc. “This machine, along with our PharmCo Medication Synchronization Program, allows us to streamline and personalize the format in which we disburse prescriptions. Physicians and patient preferences are shifting toward this type of packaging and the addition of this system will help us to solidify our 5-star performance and build brand differentiation and loyalty both in our markets and across the health care spectrum.”

Customarily used in hospital and facility settings, the Company intends to offer this convenient adherence packaging to retail patients in Miami-Dade and Broward counties. Depending on the dosage schedule, pill size, pill amount and language, this machine can provide the perfect pouch designed to make each patient’s experience more user friendly and convenient. Additionally, this new technology is easily integrated within the current pharmacy software. The TCGRx system will add to the Company’s current contingent of other pharma-robotic equipment including the ScriptPro CRS 225 and Parata PASS 208.

Similar systems have been making news headlines recently, including PillPack, which casts itself as a full-service online pharmacy that customizes the packaging in which prescriptions are delivered. In April, CNBC reported that Walmart “is looking” at buying PillPack for just under $1 billion.

For more information about Progressive Care, please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care Inc.
Progressive Care Inc. (OTCQB:RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact:
Tory Patterson, CMW Media
Public Relations Consultant
Tory@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com

Posted in Client News| Tagged |

Progressive Care Reports 30% Increase in Year-over-Year Prescriptions Filled During April 2018

MIAMI, May 17, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced that the company experienced continued year-over-year growth in its revenue and number of prescriptions filled in the month of April 2018.

Wholly-owned subsidiary PharmCo, LLC filled approximately 22,000 prescriptions during the month of April, which is an increase of 30% over the same month last year. This resulted in the generation of nearly $1.6 million in net revenues, which is an increase of 7% year-over-year.

Revenues and prescription counts continue to increase as the Company promotes its proactive patient engagement model to doctor’s offices and clinics who are looking to lower healthcare costs and provide quality service to their patients. Additionally, the company filled over $430,000 worth of prescriptions on behalf of 340B entities (not included in Net Revenues) in April, generating fees due to the pharmacy of approximately $18,000, which is over a 260% increase over the same month last year.

“We are proud to have experienced yet another month of significant growth in April. We are accustomed to aggressive formulary adjustments in April from insurance plans which generally places downward pressure on our revenue base,” said S. Parikh Mars, CEO of Progressive Care Inc. “We were able to offset this pressure through our unique ability to offer a full range of products and personalized suggested medication therapy adjustments as needed. This has allowed us to maintain patient and physician loyalty while also expanding our market share.”

“Progressive Care continues to experience reimbursement compression across the medication spectrum; however, revenue has continued to increase as a result of our dedicated sales efforts, ongoing medication diversification, and expansion of our service offerings,” added Mars.

For more information about Progressive Care, please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care, Inc. 
Progressive Care Inc. (OTCQB:RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact: 
Tory Patterson, CMW Media 
Public Relations Consultant 
Tory@cmwmedia.com 
www.cmwmedia.com

Investor Relations Contact: 
Armen Karapetyan, Progressive Care 
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com

Posted in Client News| Tagged |
Progressive Care, Inc. (RXMD)

Progressive Care Inc. Reports Largest Single Revenue Quarter in Company History

Progressive Care, Inc. (RXMD)
  • Florida-Based Healthcare, Technology and Tele-Pharmacy Services Provider Shows 24% Increase in Prescriptions Filled
  • Reports March 2018 Revenue of $1.9M as Largest Single Month in Company History

MIAMI, May 15, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology organization providing prescription pharmaceuticals, compounded medications, health risk management and tele-pharmacy services, today announced financial results for the quarter ending March 31, 2018, and provided an overview of recent operational highlights along with updates on the Company’s strategies.

The Company dispensed a total of 64,000 prescriptions in Q1, a 24% increase over Q1 2017. Revenue for the month of March 2018 was the largest single month in the Company’s history, totaling $1.9 million. For the period ending March 31, 2018, Progressive Care showed net revenue of $5,147,345, which was an increase of 7.36% year-over-year. Progressive Care’s total assets were $3,846,041 as of March 31, 2018, compared to $2,581,113 as of March 31, 2017 — an increase of 49%.

The Company continues to grow its patient base by marketing to doctors’ offices and clinics who refer their patients to the pharmacy. Healthcare providers are increasingly recommending Progressive Care subsidiary PharmCo because of its high standards of patient care and attention to performance measurements and their implications. Based on the performance in the first quarter, management expects that future growth will be driven by continued expansion into new market territories, concentrated efforts toward developing our compliance and adherence services provided to medical providers, and enhancement of technological opportunities that boost loyalty and customer satisfaction.

“The first quarter was a time of momentous growth for the Company,” said S. Parikh Mars, CEO of Progressive Care Inc. “During the first three months of the year we were able to secure a Palm Beach County location, recognize record revenues and prescriptions filled, and deliver increased value to our shareholders. We believe that our unique breadth of services and expanding penetration with customers in new markets will help us maintain sustainable growth in the future.”

Mars continued: “We are proud to have achieved clarity and efficiencies this year in an industry that is very difficult to navigate. We have come a long way since December 2017, but the hardest work is still ahead.”

FIRST QUARTER 2018 HIGHLIGHTS

During the first quarter of 2018, Progressive Care Inc. achieved the following milestones and significant events:

Reported record-breaking sales and growth numbers

  • In March 2018, the Company reported $1.9 million in revenue, the largest single month in its history to date. Progressive Care also experienced increases in prescriptions filled, reporting an 18% year-over-year increase in February, 2018, and 34% increase in January, 2018, as compared to the same months last year. As a result of the Company’s four-pillar structure (expertise in healthcare, patient care, pharmaceutical management, and customer service), Progressive Care reported a record $20 million in sales in 2017.

Officially began accepting Bitcoin for pharmacy sales

  • As part of Progressive Care’s plans to evolve its retail pharmacy’s technology and operations and enhance its e-commerce platform use, the company became one of the few pharmacies in the country to enable and accept cryptocurrency for daily purchases. PharmCo, LLC will use external payment providers, such as BitPay, to process all Bitcoin payments. This will allow the pharmacy to reach more customers who are increasingly using cryptocurrencies for daily purchases.

Furthered growth and expansion plans through pharmacy acquisition  

  • The Company signed a letter of intent to acquire a Touchpoint RX pharmacy in Palm Beach County and executed definitive agreements to close in the second quarter of 2018. The acquisition will facilitate the Company’s growth plans by increasing the delivery radius into Martin County, which includes Jupiter and Stuart, and will decrease costs of expansion and increase prescription dispensing efficiency.

Investor analyst upgraded Company’s price target to $0.35 per share

  • As a result of the Company’s significant progress with license applications in new markets, expansion in Palm Beach, and continued innovations in tele-pharmacy and the acceptance of Bitcoin for payment, SeeThruEquity initiated updated coverage and increased its price target to $0.35 per share.

Maintained steady investor relations activity  

  • The Company actively communicated with its customers and shareholders through various investor announcements and also maintained a presence at industry events. These efforts included:
    • Released an open letter to shareholders from the Company’s Chief Executive Officer, S. Parikh Mars, in January, 2018, highlighting significant achievements, key highlights in 2017, and a forward-looking statement for opportunities in 2018
    • Provided a progress report and outlook for investors in an audio interview with SmallCapVoice.com to discuss the business model, current market, achievements and goals for the Company
    • Company CEO S. Parikh Mars participated in an interview with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast to discuss its uplisting to the OTCQB

FIRST QUARTER 2018 FINANCIAL RESULTS

Net Revenue: For the period ending March 31, 2018, Progressive Care showed net revenue of $5,147,345, as compared to revenue of $4,794,376 for the period that ended March 31, 2017, an increase of 7.36%.

Balance Sheet: Total Assets for the company were $3,846,041 as of March 31, 2018, compared to $2,581,113 as of March 31, 2017, an increase of 49%.

Net Cash Provided by Operating Activities: Operating cash flow increased from $-8,641 to $309,827 year-over-year, which is an increase of over 3,000%.

For more information about Progressive Care, please visit the company’s website. Additional commentary on the company and the industry as a whole can be found on the Progressive Care blog.

About Progressive Care, Inc. 
Progressive Care, Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact: 
Tory Patterson, CMW Media 
Public Relations Consultant 
Tory@cmwmedia.com 
www.cmwmedia.com

Investor Relations Contact: 
Armen Karapetyan, Progressive Care 
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com

Posted in Interviews| Tagged |

Progressive Care Inc. Selects CMW Media as New Public Relations Agency of Record

MIAMI, May 11, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a healthcare technology services organization and provider of prescription pharmaceuticals, compounded medications and tele-pharmacy services, today announced it will partner with CMW Media as its public relations agency of record. The decision comes as part of Progressive Care’s overall effort to expand marketing and communications activities for the company and all subsidiaries.

CMW Media, a San Diego-based public relations agency specializing in publicly traded companies in emerging markets, will provide overall strategic communications planning and traditional media relations. The agency will help to develop a consistent stream of integrated communication and media campaigns to increase overall awareness of Progressive Care’s healthcare and tele-pharmacy services in the Florida market.

“We selected CMW Media as our public relations agency of record because of their team’s experience conducting successful communications campaigns for publicly traded companies in emerging markets such as healthcare technology,” said S. Parikh Mars, CEO of Progressive Care. “We are excited about this new relationship and look forward to working together.”

CMW Media will be responsible for developing and executing a robust media relations program, as well as enhancing and updating public-facing company materials, press release distribution and thought leadership positioning. These efforts will coincide with overall initiatives by the company to improve the efficacy and exposure of Progressive Care’s public information and virtual interaction with its shareholders and customers.

“We are thrilled and honored to be awarded strategic communications responsibilities for Progressive Care,” said Andrew Hard, CEO of CMW Media. “We look forward to working with the Progressive Care leadership team to help formulate their brand narrative and share their story with the masses.”

For more information about CMW Media, please visit www.cmwmedia.com or connect with us on Facebook and Twitter.

To learn more about Progressive Care, please visit www.progressivecareus.com or connect with us on social media:

Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care
Progressive Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

About CMW Media
CMW Media is a fast-growing, full-service public relations firm specializing in promoting innovative businesses from a broad spectrum of industries. Our clients range from publicly traded companies to those in emerging markets — including the global cannabis industry. We are award-winning industry leaders and producers whose inherent talent is capturing messages worldwide and educating the public. For more information, visit the Company’s website at www.CMWMedia.com.

Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Corporate Contact:
Andrew Hard, CMW Media
Chief Executive Officer
Andrew.Hard@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com

Posted in Client News| Tagged |

Progressive Care Schedules Investor Conference Call for May 15th, 2018

MIAMI, May 10, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTC.QB:RXMD), a healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Tuesday, May 15th, 2018.

“It’s been a very eventful and very successful three months…,” stated S. Parikh Mars, CEO. “We respect the importance of open communication, and enjoy keeping investors up to date on Company developments through these ongoing quarterly calls.”

On the call, S. Parikh Mars, Progressive Care Inc. CEO, will address:

  • An overview of the Company’s Q1 2018 financial results
  • Company and industry trends and developments
  • Status updates on 2018 initiatives

In addition, interested parties have the opportunity to submit questions concerning the Company prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via email: ssmith@smallcapvoice.com by 3:00 PM eastern standard time on Monday, May, 14th, 2018. Mr. Smith will compile a list of questions and submit them to the Company prior to the conference call. Which questions will be addressed will be based on the relevance to the shareholder base, and the question’s appropriateness in light of public disclosure rules.

To access the call:

Dial-In Number: 1-857-232-0157
Access Code: 422095

For those unable to participate in the live conference call, a replay will be available at https://smallcapvoice.com/blog/rxmd/ shortly after the call has concluded. An archived version of the webcast will also be available https://progressivecareus.com/investor/.

Get connected and stay in touch with us on social media:

Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care

Progressive Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Posted in Client News| Tagged |